Sentiment Analysis of the earnings transcript to help figure out if there are any bullish or bearish sentiments that could be gathered from it. We're doing ML and AI based analysis on the earnings call to get some more insights.
Please consider a small donation if you think this website provides you with relevant information
| Statement |
|---|
| Our Worksite division finished the year strong with continued insurance sales momentum and a successful fourth quarter benefits enrollment fee |
| CNO delivered strong earnings growth in the quarter and exceptional operating performance for the full year |
| Our results underscore the health and strength of our business model and lay the foundation for sustained profitable growth |
| Highlights of our full year performance include four quarters of sustained sales momentum, total new annualized premium up 9%, improvement in virtually all agent metrics across both divisions, strong net investment income results, continued strong capital position and free cash flow generation and our share price reached an all-time high |
| We delivered a solid earnings performance for the full year with operating earnings per diluted share of $3.09 |
| Stable underlying insurance product margins were bolstered by our diversified product suite |
| Now, as the agent population gets bigger, of course, it gets harder to match this type of percentage growth rates, but we feel very good about our opportunity to continue to drive both recruiting and productivity in both divisions |
| Fee income improved as we grew fee revenue and expanded margins |
| Sales production and agent force results were strong in both divisions as we posted record sales levels in multiple product categories |
| A robust calendar of successful product launches in 2023 accelerated our growth |
| Producing agent counts were up sharply, driven by recruiting and retention initiatives |
| Total health NAP was up 11% and total life NAP was up 7% with nearly all of our product lines posting sales growth |
| And everything we're seeing in 2024 leads us to believe that we should be able to continue to see good results |
| As we've built out new products, as we've bettered our sales enablement, as we've made clear the career path for these agents to become financial advisors, as we've done a number of different things, literally dozens of small, small things, I think we've made this an increasingly attractive opportunity |
| Our strong capital position remains a differentiator for CNO |
| We remain confident in our profitable growth and shareholder return opportunity |
| Our capital position, our liquidity and the cash flow generating power of the company remain robust |
| We enter 2024 well-positioned to build on our strong operating performance |
| Our sales engine has momentum and our agent force is growing |
| Our business continued to perform well in the year and we are proud of how the CNO team executed against our strategic growth priorities |
| Significant improvement in net investment income not allocated to product, which assumes that, alternative investments generate a return more in line with the long-term run rate assumption of between 9% and 10% |
| We delivered a strong production year, illustrating the value and attractiveness of our business model and approach to serving our market |
| Our unique capability to marry a virtual connection with our established in-person agent force who complete the critical last mile of sales and service delivery remains a key differentiator |
| Investment income not allocated to products increased 52% in the quarter, primarily driven by an improvement in income from alternative investments |
| On that basis, total insurance product margin posted another strong quarter with some puts and takes across products, highlighting the value of our diverse product mix |
| We're also well positioned from a capital perspective with the recent formation of CNO Bermuda Re, and the initial treaty between our Illinois based operating company and the new Bermuda company, which settled on November 30 with an October 1 effective date |
| Direct-to-consumer life was up 3%, reflecting six consecutive years of growth and record results in 2023 |
| The underlying trends evident in our strong third and fourth quarter results position us well for solid earnings growth going forward |
| Long-term care NAP was up 27% on the strength of our new long-term care fundamental plus product |
| Fee income in the quarter was up 31% with solid growth in net advantage sales, despite reduced advertising and lead spend |
| Statement |
|---|
| That creates a little bit of a headwind for us in terms of year-over-year margin comparisons in that product |
| And then the last thing I'd say, and again, you've seen this in the results, the new Med Supp product that we introduced, I think it's been a little over a year now, is not as profitable as the old Med Supp product that's now running off |
| And second, elevated health claims during the second quarter, which moderated as expected during the second half of the year |
| But we are seeing some pressure on claims |
| Fee income to be slightly down year-over-year with roughly a quarter of the full year earnings coming in the first quarter and the balance coming in the fourth quarter with the second and third quarters roughly breakeven, and no change to our expected effective tax rate of 23% |
| Number one, lower alternative investment income, which is volatile by definition |
| The low end of the range assumes a departure from the status quo, in particular that we accelerate organic growth or we take more risk in our investment portfolio and/or economic conditions deteriorate, prompting adverse credit migration |
| There's probably more downside risk there than upside |
| But over the course of the next 12 months, I think it's not an unrealistic expectation |
| So we didn't include ROE in our guidance, and that's primarily because the non-operating income can create some sort of unplanned noise in the ratio |
| I think it's an example of something that can put pressure on loss costs that we respond to with rate increases |
| But I think what's really happened and why we've had such performance, it's a little bit like Jim Collins analogy of the flywheel |
| It's not going to be a steady state |
| We generated $311 million in excess cash flow to the holding company for the year, slightly below our guidance, but excess capital relative to our target RBC and holdco liquidity levels was in line with our expectations |
| Number one, it's variable by definition, and it's -- so it's going to be volatile |
Please consider a small donation if you think this website provides you with relevant information